# FDA 483 - Angiplast Private Limited - January 30, 2020

Source: https://www.globalkeysolutions.net/records/483/angiplast-private-limited/0a4ad4c2-484f-420c-a289-577ab8c5cf73

> FDA 483 for Angiplast Private Limited on January 30, 2020. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Angiplast Private Limited
- Inspection Date: 2020-01-30
- Product Type: device
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [WARNING_LETTER - 2020-01-30](https://www.globalkeysolutions.net/records/warning_letter/angiplast-private-limited/82e6ec99-87a4-44c1-8b00-8912ba773b94)
- [483 - 2020-01-30](https://www.globalkeysolutions.net/records/483/angiplast-private-limited/686c9eb9-54a9-4fa9-9e7e-f00b600127ad)
- [483 - 2020-01-30](https://www.globalkeysolutions.net/records/483/angiplast-private-limited/d3ed0103-c5e9-4d28-abdd-33a7c739c149)

## Related Officers

- [Consultant](https://www.globalkeysolutions.net/people/seema-singh/7f3f7209-1749-46ee-8829-f305c5512e38)

Company: https://www.globalkeysolutions.net/companies/angiplast-private-limited/4c0a40cd-74d5-4d59-abb5-64fc1323e37f

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd